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pathophysiology is based on arterial spasm in different segments of the arterial tree. Ergot-alkaloids are frequently prescribed
as treatment for severe migraine. Ergotamine overdose is often based on interactions with other drugs using the same
metabolic pathway. We report a case of a 28 year old HIV positive male patient on protease-inhibitors, who developed
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